Post-divestiture deleveraging halved total debt to $3.1B and reduced D/E to 0.23, while cash more than doubled to $1.7B, but goodwill of $7.8B (37% of assets) and negative retained earnings of -$24.3B warrant scrutiny.
DuPont de Nemours, Inc. (DD) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 4.86B | 5.58B | 6.36B | 7.51B | 11.27B | 14.3B | 29.01B | 10B | 126.66B | 49.89B | 23.66B | 23.94B | 24.25B | 24.98B | 23.68B | 23.42B | 23.78B | 19.56B | 16.06B | 18.65B | 17.21B | 17.4B | 15.89B | 13B | 11.68B | 10.31B | 11.32B | 8.85B | 8.04B | 8.64B | 9.83B |
| Cash & Short-Term Investments | 1.74B | 757M | 1.85B | 2.39B | 4.96B | 1.97B | 2.54B | 1.54B | 8.58B | 14.39B | 6.61B | 8.58B | 5.65B | 5.94B | 4.32B | 5.45B | 7.04B | 2.85B | 2.8B | 1.74B | 2.91B | 3.84B | 3.19B | 2.43B | 1.57B | 264M | 441M | 1.21B | 123M | 235M | 1.9B |
| Cash Only | 1.74B | 757M | 1.85B | 2.39B | 3.66B | 1.97B | 2.54B | 1.54B | 8.55B | 13.44B | 6.61B | 8.58B | 5.65B | 5.94B | 4.32B | 5.44B | 7.04B | 2.85B | 2.8B | 1.74B | 2.76B | 3.81B | 3.11B | 2.39B | 1.48B | 220M | 278M | 506M | 123M | 235M | 1.9B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 1.3B | 0 | 0 | 0 | 29M | 956M | 0 | 0 | 0 | 0 | 0 | 2M | 0 | 0 | 0 | 1M | 153M | 32M | 84M | 42M | 89M | 44M | 163M | 706M | 0 | 0 | 0 |
| Accounts Receivable | 1.75B | 1.67B | 2.2B | 2.37B | 2.52B | 2.16B | 2.42B | 3.83B | 3.39B | 16.89B | 9.02B | 7.85B | 9.37B | 9.65B | 9.68B | 9.63B | 9.04B | 9.2B | 6.86B | 9.68B | 8.05B | 7.93B | 7.36B | 5.82B | 5.49B | 5.1B | 6.42B | 4.61B | 4.54B | 4.96B | 4.4B |
| Days Sales Outstanding | 82.73 | 88.95 | 64.8 | 71.68 | 70.61 | 62.71 | 61.63 | 65.05 | 54.78 | 98.68 | 68.41 | 58.8 | 58.9 | 61.76 | 62.21 | 58.57 | 61.5 | 74.79 | 43.76 | 66.05 | 59.8 | 62.47 | 66.86 | 65.1 | 72.51 | 66.92 | 101.83 | 84.25 | 85.18 | 90.4 | 80.02 |
| Inventory | 1.21B | 1.17B | 2.13B | 2.15B | 2.33B | 2.09B | 2.39B | 4.32B | 4.11B | 16.99B | 7.36B | 6.87B | 8.1B | 8.3B | 8.48B | 7.58B | 7.09B | 6.85B | 6.04B | 6.88B | 6.06B | 5.32B | 4.96B | 4.05B | 4.21B | 4.44B | 3.46B | 2.79B | 2.81B | 2.92B | 2.81B |
| Days Inventory Outstanding | 91.37 | 89.55 | 91.75 | 92.91 | 94.54 | 89.19 | 87.57 | 104.36 | 91.71 | 126.34 | 71.49 | 65.8 | 61.91 | 63.42 | 64.23 | 53.82 | 56.15 | 63.87 | 42.73 | 54.19 | 53.26 | 50.76 | 52.73 | 52.46 | 64.59 | 68.52 | 74.04 | 71.58 | 75.51 | 79.31 | 80.16 |
| Other Current Assets | 42M | 1.98B | 185M | 194M | 1.45B | 7.92B | 21.49B | 306M | 110.49B | 1.61B | 711M | 647M | 1.12B | 1.09B | 1.21B | 773M | 611M | 672M | 368M | 348M | 193M | 321M | 384M | 698M | 415M | 506M | -29M | 235M | 570M | 526M | 716M |
| Total Non-Current Assets | 16.2B | 16B | 30.27B | 31.04B | 30.09B | 31.4B | 41.9B | 59.35B | 61.2B | 142.27B | 55.85B | 44B | 44.43B | 44.52B | 45.92B | 45.8B | 45.81B | 46.38B | 29.41B | 30.15B | 28.37B | 28.53B | 30B | 28.89B | 27.88B | 25.21B | 18.39B | 16.65B | 15.79B | 15.4B | 14.84B |
| Property, Plant & Equipment | 3.38B | 3.46B | 5.77B | 6.37B | 5.73B | 6.17B | 7.29B | 10.14B | 9.92B | 36.25B | 23.49B | 17.85B | 18.05B | 17.45B | 17.52B | 17.3B | 17.67B | 18.14B | 14.29B | 14.39B | 13.72B | 13.54B | 13.83B | 14.22B | 13.8B | 13.58B | 9.19B | 8.49B | 8.45B | 8.05B | 8.48B |
| Fixed Asset Turnover | 2.09x | 1.98x | 2.15x | 1.90x | 2.27x | 2.03x | 1.97x | 2.12x | 2.28x | 1.72x | 2.05x | 2.73x | 3.22x | 3.27x | 3.24x | 3.47x | 3.04x | 2.47x | 4.00x | 3.72x | 3.58x | 3.42x | 2.90x | 2.30x | 2.00x | 2.05x | 2.50x | 2.35x | 2.30x | 2.49x | 2.36x |
| Goodwill | 7.84B | 7.92B | 16.57B | 16.72B | 16.66B | 16.98B | 18.7B | 33.15B | 34.5B | 59.53B | 15.27B | 12.15B | 12.63B | 12.8B | 12.74B | 12.93B | 12.97B | 13.11B | 3.39B | 3.57B | 3.24B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.79B | 2.94B | 5.37B | 5.81B | 5.5B | 6.22B | 8.07B | 13.59B | 14.65B | 33.27B | 6.03B | 3.62B | 3.77B | 4.31B | 4.71B | 5.06B | 5.53B | 5.97B | 829M | 781M | 457M | 3.58B | 3.69B | 3.81B | 3.8B | 3.13B | 1.89B | 1.83B | 1.64B | 1.76B | 899M |
| Long-Term Investments | 3.3B | 432M | 1.08B | 1.07B | 733M | 919M | 1.05B | 1.26B | 1.77B | 7.9B | 6.72B | 6.88B | 6.64B | 7.04B | 6.69B | 5.91B | 6.38B | 6B | 5.72B | 5.96B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 995M | 971M | 1.24B | 753M | 1.35B | 991M | 6.59B | 1.01B | 134M | 3.45B | 1.27B | 1.35B | 1.21B | 952M | 932M | 2.04B | 1.18B | 1.12B | 1.27B | 3.32B | 6.95B | 7.75B | 8.11B | 6.75B | 6.81B | 6.25B | 7.31B | 6.33B | 5.7B | 5.59B | 5.46B |
| Total Assets | 21.06B | 21.57B | 36.64B | 38.55B | 41.35B | 45.71B | 70.9B | 69.35B | 187.85B | 192.16B | 79.51B | 67.94B | 68.69B | 69.5B | 69.61B | 69.22B | 69.59B | 65.94B | 45.47B | 48.8B | 45.58B | 45.93B | 45.88B | 41.89B | 39.56B | 35.52B | 35.99B | 25.5B | 23.83B | 24.04B | 24.67B |
| Asset Turnover | 0.32x | 0.32x | 0.34x | 0.31x | 0.31x | 0.27x | 0.20x | 0.31x | 0.12x | 0.33x | 0.61x | 0.72x | 0.85x | 0.82x | 0.82x | 0.87x | 0.77x | 0.68x | 1.26x | 1.10x | 1.08x | 1.01x | 0.88x | 0.78x | 0.70x | 0.78x | 0.64x | 0.78x | 0.82x | 0.83x | 0.81x |
| Asset Growth % | -122.33% | -41.11% | -4.97% | -6.78% | -9.52% | -35.54% | 2.24% | -63.08% | -2.24% | 141.68% | 17.03% | -1.09% | -1.17% | -0.15% | 0.55% | -0.52% | 5.54% | 45% | -6.82% | 7.06% | -0.77% | 0.11% | 9.53% | 5.89% | 11.4% | -1.32% | 41.15% | 7% | -0.87% | -2.57% | 4.63% |
| Total Current Liabilities | 2B | 2.31B | 4.8B | 3.1B | 3.73B | 4.93B | 12.23B | 8.35B | 73.31B | 26.13B | 12.6B | 11.12B | 11.59B | 11.97B | 11.49B | 13.63B | 13.9B | 13.11B | 13.11B | 12.45B | 10.6B | 10.66B | 10.51B | 9.53B | 8.86B | 8.13B | 10.17B | 6.29B | 6.84B | 7.34B | 6B |
| Accounts Payable | 978M | 995M | 1.72B | 1.68B | 2.1B | 2.1B | 2.22B | 2.93B | 2.62B | 9.13B | 4.52B | 3.58B | 4.48B | 4.59B | 5.01B | 4.78B | 4.36B | 3.99B | 2.98B | 4.25B | 4.64B | 4.63B | 5.89B | 4.88B | 2.83B | 3.64B | 4.57B | 2.87B | 2.66B | 2.69B | 2.32B |
| Days Payables Outstanding | 75.95 | 76.03 | 74.09 | 72.48 | 85.36 | 89.87 | 81.31 | 70.89 | 58.48 | 67.91 | 43.88 | 34.26 | 34.25 | 35.06 | 37.96 | 33.94 | 34.51 | 37.19 | 21.12 | 33.48 | 40.83 | 44.14 | 62.71 | 63.27 | 43.5 | 56.16 | 97.69 | 73.71 | 71.56 | 73.07 | 66.06 |
| Short-Term Debt | 0 | 60M | 1.85B | 0 | 300M | 150M | 1M | 3.83B | 15M | 4.01B | 907M | 995M | 933M | 1.14B | 1.07B | 3.29B | 3.22B | 3.22B | 3.81B | 2.13B | 1.51B | 1.52B | 965M | 1.35B | 1.38B | 1.62B | 2.84B | 1.03B | 1.83B | 2.06B | 1.27B |
| Deferred Revenue (Current) | 4M | 0 | 0 | 0 | 0 | 0 | 16M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 241M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 53M | 1.25B | 0 | 0 | 146M | 1.63B | 8.62B | 724M | 69.43B | 7.07B | 2.1B | 4.97B | 1.55B | 4.71B | 4.45B | 4.58B | 4.95B | 4.73B | 4.53B | 4.21B | 4.01B | 3.98B | 2.48B | 3.06B | 2.35B | 749M | 510M | 2.39B | 2.35B | 2.59B | 2.41B |
| Current Ratio | 2.43x | 2.42x | 1.33x | 2.43x | 3.02x | 2.90x | 2.37x | 1.20x | 1.73x | 1.91x | 1.88x | 2.15x | 2.09x | 2.09x | 2.06x | 1.72x | 1.71x | 1.49x | 1.23x | 1.50x | 1.62x | 1.63x | 1.51x | 1.36x | 1.32x | 1.27x | 1.11x | 1.41x | 1.18x | 1.18x | 1.64x |
| Quick Ratio | 1.82x | 1.91x | 0.88x | 1.73x | 2.40x | 2.48x | 2.18x | 0.68x | 1.67x | 1.26x | 1.29x | 1.54x | 1.39x | 1.39x | 1.32x | 1.16x | 1.20x | 0.97x | 0.76x | 0.95x | 1.05x | 1.13x | 1.04x | 0.94x | 0.84x | 0.72x | 0.77x | 0.96x | 0.76x | 0.78x | 1.17x |
| Cash Conversion Cycle | 98.14 | 102.47 | 82.46 | 92.11 | 79.78 | 62.03 | 67.89 | 98.52 | 88.01 | 157.11 | 96.03 | 90.34 | 86.57 | 90.12 | 88.48 | 78.45 | 83.14 | 101.47 | 65.38 | 86.76 | 72.22 | 69.1 | 56.89 | 54.3 | 93.6 | 79.28 | 78.19 | 82.12 | 89.13 | 96.65 | 94.11 |
| Total Non-Current Liabilities | 5.18B | 5.17B | 8.04B | 10.73B | 10.61B | 13.73B | 19.61B | 19.45B | 18.64B | 64.11B | 39.68B | 30.64B | 33.75B | 29.61B | 36.24B | 32.3B | 33.05B | 31.79B | 18.79B | 16.55B | 17.55B | 19.61B | 22.66B | 22.81B | 22.71B | 17.04B | 13.53B | 9.92B | 8.98B | 8.35B | 8.59B |
| Long-Term Debt | 3.13B | 3.13B | 5.32B | 7.79B | 7.77B | 10.63B | 15.61B | 13.62B | 12.62B | 30.06B | 20.46B | 16.21B | 18.74B | 16.82B | 19.92B | 18.31B | 20.61B | 19.15B | 8.04B | 7.58B | 8.04B | 9.19B | 11.63B | 11.76B | 11.66B | 9.27B | 6.61B | 5.02B | 4.05B | 4.2B | 4.2B |
| Capital Lease Obligations | 285M | 0 | 0 | 10M | 0 | 339M | 310M | 418M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 1.79B | 405M | 915M | 1.13B | 1.16B | 1.46B | 0 | 3.47B | 0 | 6.27B | 923M | 587M | 622M | 718M | 837M | 1.09B | 1.29B | 1.28B | 746M | 854M | 999M | 1.4B | 1.3B | 1.12B | 994M | 760M | 887M | 839M | 747M | 649M | 1B |
| Other Non-Current Liabilities | 1.76B | 1.63B | 1.8B | 1.8B | 1.67B | 1.3B | 3.69B | 1.95B | 6.02B | 27.79B | 18.3B | 13.84B | 14.39B | 12.07B | 15.49B | 12.9B | 11.15B | 11.35B | 10B | 7.12B | 8.52B | 9.03B | 8.73B | 8.92B | 9.06B | 6.01B | 6.03B | 4.06B | 4.19B | 3.5B | 3.39B |
| Total Liabilities | 7.18B | 7.47B | 12.84B | 13.83B | 14.34B | 18.66B | 31.83B | 27.79B | 91.95B | 90.24B | 52.28B | 41.76B | 45.33B | 41.58B | 47.74B | 45.93B | 46.95B | 44.81B | 31.89B | 29B | 28.15B | 30.27B | 33.17B | 32.34B | 31.57B | 25.16B | 23.7B | 16.22B | 15.83B | 15.69B | 14.59B |
| Total Debt | 3.13B | 3.19B | 7.17B | 7.8B | 8.07B | 11.21B | 16.04B | 18B | 12.64B | 34.07B | 21.36B | 17.21B | 19.67B | 17.96B | 20.99B | 21.6B | 23.83B | 22.37B | 11.86B | 9.71B | 9.55B | 10.71B | 12.59B | 13.11B | 13.04B | 10.88B | 9.45B | 6.06B | 5.88B | 6.26B | 5.47B |
| Net Debt | 1.39B | 2.44B | 5.32B | 5.41B | 4.41B | 9.24B | 13.49B | 16.46B | 4.09B | 20.63B | 14.76B | 8.63B | 14.02B | 12.02B | 16.67B | 16.16B | 16.79B | 19.53B | 9.06B | 7.98B | 6.79B | 6.9B | 9.49B | 10.72B | 11.55B | 10.66B | 9.17B | 5.55B | 5.75B | 6.02B | 3.56B |
| Debt / Equity | 0.23x | 0.23x | 0.30x | 0.32x | 0.30x | 0.41x | 0.41x | 0.43x | 0.13x | 0.33x | 0.78x | 0.66x | 0.84x | 0.64x | 0.96x | 0.93x | 1.05x | 1.06x | 0.87x | 0.49x | 0.55x | 0.68x | 0.99x | 1.37x | 1.63x | 1.05x | 0.77x | 0.65x | 0.73x | 0.75x | 0.54x |
| Debt / EBITDA | 1.77x | 2.12x | 2.37x | 2.72x | 2.56x | 3.76x | 4.70x | 3.71x | 2.93x | 3.05x | 2.40x | 2.00x | 2.37x | 2.51x | 3.10x | 3.06x | 3.78x | 4.81x | 2.59x | 1.58x | 1.39x | 1.42x | 2.30x | 3.34x | 4.46x | 3.65x | 2.73x | 1.78x | 1.74x | 1.60x | 1.26x |
| Net Debt / EBITDA | 0.78x | 1.62x | 1.76x | 1.89x | 1.40x | 3.10x | 3.96x | 3.39x | 0.95x | 1.85x | 1.66x | 1.00x | 1.69x | 1.68x | 2.46x | 2.29x | 2.66x | 4.20x | 1.98x | 1.30x | 0.99x | 0.92x | 1.73x | 2.73x | 3.95x | 3.57x | 2.65x | 1.63x | 1.70x | 1.54x | 0.82x |
| Interest Coverage | 3.22x | 1.64x | 4.26x | 2.27x | 3.94x | 3.75x | -2.34x | 0.29x | 11.91x | - | 6.14x | 11.50x | 6.36x | 7.18x | 2.31x | 3.68x | 2.90x | 1.30x | 2.97x | 8.26x | 8.87x | 9.86x | 6.08x | - | - | - | - | - | - | - | - |
| Total Equity | 13.88B | 14.1B | 23.79B | 24.73B | 27.02B | 27.05B | 39.07B | 41.56B | 95.9B | 101.93B | 27.23B | 26.18B | 23.35B | 27.92B | 21.87B | 23.29B | 22.64B | 21.12B | 13.58B | 19.8B | 17.43B | 15.66B | 12.72B | 9.55B | 7.99B | 10.35B | 12.25B | 9.28B | 8B | 8.35B | 10.08B |
| Equity Growth % | -125.84% | -40.73% | -3.77% | -8.48% | -0.12% | -30.77% | -5.98% | -56.67% | -5.91% | 274.33% | 4% | 12.11% | -16.37% | 27.7% | -6.11% | 2.87% | 7.19% | 55.55% | -31.42% | 13.61% | 11.3% | 23.12% | 33.17% | 19.51% | -22.78% | -15.51% | 31.99% | 15.95% | -4.16% | -17.14% | 6.35% |
| Book Value per Share | 101.17 | 100.93 | 169.71 | 164.39 | 162.30 | 149.12 | 159.36 | 167.05 | 372.75 | 574.02 | 218.18 | 189.82 | 177.07 | 194.76 | 167.29 | 180.99 | 178.16 | 180.39 | 130.16 | 184.58 | 160.99 | 144.29 | 120.02 | 92.82 | 79.00 | 103.29 | 122.78 | 126.10 | 108.96 | 106.70 | 125.39 |
| Total Shareholders' Equity | 13.77B | 13.92B | 23.35B | 24.28B | 26.57B | 26.43B | 38.5B | 40.99B | 94.29B | 100.33B | 25.99B | 25.37B | 22.42B | 26.9B | 20.88B | 22.28B | 21.84B | 20.55B | 13.51B | 19.39B | 17.07B | 15.32B | 12.27B | 9.18B | 7.63B | 9.99B | 11.84B | 8.87B | 7.47B | 7.67B | 7.99B |
| Common Stock | 1M | 4M | 4M | 4M | 5M | 5M | 7M | 7M | 8M | 23M | 3.11B | 3.11B | 3.11B | 3.05B | 3.01B | 2.96B | 2.93B | 2.91B | 2.45B | 2.45B | 2.45B | 2.45B | 2.45B | 2.45B | 2.45B | 2.45B | 2.45B | 818M | 0 | 0 | 0 |
| Retained Earnings | -24.33B | -24.28B | -23.08B | -22.87B | -21.07B | -23.19B | -11.59B | -8.4B | 30.26B | 29.21B | 30.34B | 28.43B | 23.05B | 21.41B | 18.5B | 19.09B | 17.74B | 16.7B | 17.01B | 18B | 16.99B | 14.72B | 11.53B | 9.99B | 9.52B | 11.11B | 12.68B | 13.45B | 12.89B | 12.36B | 11.32B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.42B | -1B | -1.66B | -6.16B | -4.23B | -307M | 0 | 0 | -239M | -557M | -2.44B | -1.8B | -970M | -559M | -995M | -1.76B | -2.19B | -2.41B | -2.63B | -7.01B | 0 | 0 | 0 |
| Accumulated OCI | -616M | -525M | -1.5B | -910M | -791M | 41M | 44M | -1.42B | -12.53B | -8.97B | -10.06B | -8.67B | -8.02B | -5.18B | -7.52B | -6B | -4.4B | -3.89B | -4.17B | -170M | -2.23B | -559M | -989M | -1.52B | -2.16B | -1.16B | -663M | -251M | 0 | 0 | 0 |
| Minority Interest | 112M | 184M | 443M | 446M | 448M | 617M | 566M | 569M | 1.61B | 1.6B | 1.24B | 809M | 931M | 1.03B | 990M | 1.01B | 803M | 569M | 69M | 414M | 365M | 336M | 449M | 376M | 366M | 357M | 410M | 408M | 532M | 676M | 2.09B |
Quick answers to the most common questions about buying DD stock.
As of 2025, DuPont de Nemours, Inc. (DD) had total assets of $21.57B including $5.58B in current assets.
DuPont de Nemours, Inc. (DD) carries total debt of $3.19B, offset by $757.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
DuPont de Nemours, Inc. (DD) has total shareholders' equity (book value) of $13.92B ($100.93 book value per share). Book value represents the net worth of the company belonging to common stock holders.
DuPont de Nemours, Inc. (DD) reported a current ratio of 2.42x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
PFAS litigation overhang
Metrics are mathematically derived from official filings.
Balance Sheet Reshaped by Divestitures
Total assets contracted from $37.7B in 2024Q1 to $21.1B in 2026Q2, reflecting the Mobility & Materials divestiture, while equity fell from $23.6B to $13.8B, according to reported balance sheet data.
The dramatic reduction in asset base and equity is consistent with the portfolio reshaping, but the balance sheet appears to have stabilized in recent quarters, with assets hovering around $21-22B. The decline in goodwill from $16.6B to $7.8B suggests a significant write-off or disposal of acquired intangibles, which may indicate that the remaining goodwill is more closely tied to core operations. Investors should monitor whether the smaller asset base can generate higher returns on equity, as the divestiture was intended to improve capital efficiency.
Leverage Halved Post-Divestiture
Total debt fell from $7.7B in 2024Q1 to $3.1B in 2026Q2, driving the debt-to-equity ratio down from 0.32 to 0.23, as per the latest balance sheet figures, indicating a conservative leverage profile.
The reduction in debt is a direct result of using divestiture proceeds to pay down obligations, which has strengthened the balance sheet. With a D/E of 0.23, DuPont is significantly less leveraged than peers like Dow (1.12) and LyondellBasell (1.56), suggesting ample financial flexibility. However, the absolute debt level of $3.1B still requires servicing, and the company's ability to generate consistent cash flow from a smaller revenue base will be key to maintaining this low leverage.
Asset Mix Shifts to Intangibles
Goodwill now represents 37% of total assets, up from 44% pre-divestiture, while net PPE fell from $6.2B to $3.4B, based on the balance sheet data, indicating a more asset-light, intangibles-heavy structure.
The reduction in PPE reflects the divestiture of manufacturing assets, leaving a more focused specialty chemicals portfolio. The high proportion of goodwill suggests that acquisitions have been a key growth strategy, but this also raises impairment risk if the acquired businesses underperform. The shift towards intangibles is typical of a company moving up the value chain, but investors should assess whether the remaining goodwill is supported by robust cash flows from the Electronics & Industrial and Water & Protection segments.
Equity Quality Masked by Deficit
Retained earnings remain deeply negative at -$24.3B in 2026Q2, yet total equity stands at $13.8B, according to the balance sheet, suggesting that equity is largely supported by paid-in capital and other reserves.
The negative retained earnings balance is a legacy of past losses and dividends, but the equity base remains positive due to substantial contributed capital. This structure implies that the company has historically returned more to shareholders than it has earned, which may limit future dividend growth unless profitability improves. The recent resumption of buybacks, as noted in the cash flow analysis, indicates management's confidence in the equity base, but the negative retained earnings warrant monitoring for any further deterioration.
Liquidity Strengthens with Cash Build
Cash more than doubled from $752M in 2026Q1 to $1.7B in 2026Q2, while the current ratio improved to 2.43, as per the balance sheet data, providing a solid buffer against short-term obligations.
The increase in cash is likely a result of divestiture proceeds and improved working capital management, boosting liquidity to a level that comfortably covers current liabilities. The current ratio of 2.43 is above the peer average, indicating strong short-term solvency. However, the cash balance is still modest relative to the company's size, and the lack of deferred revenue suggests limited visibility into future cash flows, so the liquidity position should be viewed as adequate but not excessive.
Goodwill Impairment Risk Lingers
Goodwill of $7.8B represents 37% of total assets, and with revenue down 44.7% YoY, the carrying value may be at risk of impairment, according to the balance sheet data, warranting close scrutiny.
The massive revenue contraction, even if divestiture-driven, reduces the earnings power that supports goodwill valuations. If the remaining segments fail to deliver expected growth, DuPont could face significant non-cash impairment charges, which would further erode equity. Additionally, the negative retained earnings and ongoing PFAS litigation create a complex risk profile that headline leverage metrics do not capture. Investors should monitor segment-level performance and any goodwill impairment testing disclosures in future filings.